Form S-3ASR CRISPR Therapeutics AG

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Form S-3ASR CRISPR Therapeutics AG

CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital

August 6, 2024 6:43 AM EDT

RBC Capital analyst Luca Issi lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $60.00 (from $66.00) while maintaining a Sector Perform rating.

The analyst comments "Casgevys launch is under way with >35 ATCs activated (vs >25 last Q) and cells collected from 20... More